Schizophrenia
- In adolescents presenting with problem behaviours, consider schizophrenia in the differential diagnosis.
- In “apparently” stable patients with schizophrenia (e.g., those who are not floridly psychotic), provide regular or periodic assessment in a structured fashion e.g., positive and negative symptoms, their performance of activities of daily living, and the level of social functioning at each visit:
- seeking collateral information from family members and other caregivers to develop a more complete assessment of symptoms and functional status;
- competency to accept or refuse treatement, and document specifically;
- suicidal and homicidal ideation, as well as the risk for violence;
- medication compliance and side effects.
- In all patients presenting with psychotic symptoms, inquire about substance use and abuse.
- Consider the possibility of substance abuse and look for it in patients with schizophrenia, as this is a population at risk.
- In patients with schizophrenia, assess and treat substance abuse appropriately.
- In decompensating patients with schizophrenia, determine:
- if substance abuse is contributory.
- the role of medication compliance and side-effect problems.
- if psychosocial supports have changed.
- Diagnose and treat serious complications/side effects of antipsychotic medications (e.g., neuroleptic malignant syndrome, tardive dyskinesia).
- Include psychosocial supports (e.g., housing, family support, disability issues, vocational rehabilitation) as part of the treatment plan for patients with schizophrenia.
General Overview
General Overview
- Delusions
- Persecutory
- Grandiose
- Erotomanic (eg. movie star is in love with them)
- Somatic (eg. sinuses infested by worms)
- Delusions of reference (eg. dialogue on TV directed towards patient)
- Delusions of control (eg. thoughts/movements controlled by others)
- Hallucinations
- Auditory (most common)
- Visual
- Tactile
- Olfactory
- Gustatory
- Thought disorganization
- Alogia/poverty of content – Very little information conveyed by speech
- Thought blocking – Suddenly losing train of thought, exhibited by abrupt interruption in speech
- Loosening of association
- Tangentiality – (circumstantiality if content eventually returns to original topic)
- Clanging or clang association – Using words in a sentence that are linked by rhyming or phonetic similarity (eg, “I fell down the well sell bell.”)
- Word salad – Real words are linked together incoherently, yielding nonsensical content
- Perseveration – Repeating words or ideas persistently, often even after interview topic has changed
DSM-5 Diagnosis
DSM-5 Diagnosis
- ≥2 for most of the month (with one of the first three)
- Delusions (eg. perscution, passivity [thoughts/actions controlled by external force])
- Hallucinations
- Disorganized Speech
- Grossly disorganized or catatonic behavior
- Negative symptoms (eg. avolition, diminished emotional expression)
- Marked dysfunction
- r/o schizoaffective, depression, bipolar
DDx Psychosis
DDx Psychosis
- Psychiatric
- Brief psychotic disorder >1d-1mo
- Schizophreniform >1mo - <6mo
- Schizophrenia >6mo
- Schizoaffective (major mood episode, and >2w of delusions/hallucination in absence of mood)
- Bipolar I with psychotic features
- Major depressive disorder with psychotic features
- Personality disorder (schizotypal, borderline)
- PTSD
- ADHD, CD, ODD
- Substance-induced psychotic disorder
- Medical
- Autoimmune (SLE, MS)
- Infection (HIV, Neurosyphilis, HSV encephalitis, Lyme, Prion disorders)
- Endocrine (Thyroid, parathyroid, adrenal)
- Metabolic (Wilson's disease, acute intermittent porphyria)
- Dementia
- Neurologic (trauma, lesion, seizure, stroke)
- B12 deficiency
- Malignancy
- Medication
- Delirium
Screening
Screening
- Do you ever hear voices when you are alone? What do these voices say to you?
- Do you ever feel that people are talking about you behind your back? Or that they are out to get you?
- Do you ever think that people can pick up on or control what you are thinking?
History
History
- Symptoms
- Function
- Suicide
- Head trauma (r/o subdural hematoma)
- Recent stressors and Supports
- Substance use
- Medication and adherence
- Family Hx
- Collateral
Investigations
Investigations
- CBC +/- blood culture
- Electrolytes
- LFT
- TSH
- Syphilis screen
- HIV
- UA +/- urine culture
- Urine drug screen
- B12
- Consider Head CT/MRI
- Consider baseline EKG, lipids
Management
Management
- Family intervention and CBT
- Housing, vocational, financial support, social worker
- Admission, day-time inpatient care
- Detoxification
- Agitation PRN Cocktail (LAB) - can mix all three in one syringe
- Loxapine 25-50mg PO/IM q1-2h or Haldol 5mg IM q1-2h (max 4/24h)
- Ativan 1-2mg PO/IM q1-2h
- Benadryl 25-50mg PO/IM q1-2h
- Atypical antipsychotic
- Risperidone 1-6mg/day smallest risk for metabolic side effects
- Clozapine for non-responders
- Adverse: agranulocytosis, seizure, myocarditis, cardiomyopathy
- Follow q3 months until stable
- Signs/symptoms
- Function
- Suicidal/aggressive thoughts/behaviour
- Substance use
- BMI
- Labs: Fasting glucose/Lipids baseline, 3mo, then yearly
Follow-up
Follow-up
- Positive and negative symptoms
- Suicidal, homicidal ideation
- Function (social, home, ADLs)
- Psychosocial supports
- Medication adherence
- Medication side effects
- EPS, hyperprolactinemia, cardiometabolic risk (weight gain, diabetes, dyslipidermia), anticholinergic, antihistamine (sedation), antiadrenergic (orthostatic hypotension)
- Substance use
Extrapyramidal Symptoms (EPS)
Extrapyramidal Symptoms (EPS)
- Consider antipsychotic dose reduction
- Consider switching to agent with less EPS
- Consider dystonia prophylaxis if treating with haloperidol or high risk
- Acute Dystonia (hours-5days, involuntary contractions of major muscle groups)
- Severe - Benztropine 1-2mg IM/IV or Diphenhydramine 25mg IM
- Mild - Benztropine 1-2mg PO daily
- Akathisia (restlessness, most common EPS)
- Beta-blocker - Propranolol 10mg (to 40mg) PO BID
- Anticholinergic - Benztropine 1-2mg PO BID
- Benzodiazepine - Lorazepam 0.5mg PO BID
- Parkinsonism (mask facies, resting tremor, rigidity, shuffling gait, bradykinesia)
- Anticholinergic - Benztropine 1-2mg PO BID
- Non-anticholinergic - Amantadine 100mg PO BID-TID
- Tardive dyskinesia (years of treatment - lip smacking, facial grimace, jaw movements, choreiform movements of extremities/trunk)
- Switch to antipsychotic with low risk TD (quetiapine, clozapine)
- Benzodiazepine - Clonazepam
- Other - Botox injections, tetrabenazine, anticholinergic, deep brain stimulation
Neuroleptic Malignant Syndrome
Neuroleptic Malignant Syndrome
- Altered mental status, rigidity, hyperthermia (>38-40C), dysautonomia (tachycardia, hypertension, tachypnea)
- In the setting of neuroleptic use of dopamine withdrawal
- r/o infection (eg. meningitis) or drug-induced
- r/o serotonin syndrome (shivering, hyperreflexia, myoclonus, ataxia, GI symptoms)
- Treatment
- Stop neuroleptic
- ICU - aggressive supportive therapy
- Treat hyperthermia
- Follow serum CK
- Consider benzodiazepines, dantrolene, bromocriptine, amantadine if no response to supportive care within 1-2d
References:
